CVS HEALTH Corp

NYSE: CVS·Woonsocket, Rhode Island·

Price
$88.59
Base IV
$232.05

Valuation snapshot

Below bear case

At $88.59, the price is below even our bear case of $135.83.

Values per share, from an .

No growth
…
Loading earnings power
Base case
$232.05
above today's price · range $135.83–$366.46
Price vs base case
62% below
$88.59 against $232.05
Base casevalued by DCF
Price vs base
Priceclose 11‑16

The price has risen 10.8% since this valuation was struck on 2026-11-05, so some of the gap opened up after these figures were set.

Whisker on the base case runs bear $135.83 to bull $366.46. Values per share.

Price against each value

Bear case
$135.83
Price 35% below
No growth
…
—
Base case
$232.05
Price 62% below
Researched bygemini-3.8-flash-medium
Valuation Nov 5, 2026 · Price as of Nov 16, 2026How we got here

What does CVS Health do?

CVS Health provides health insurance, pharmacy benefits management, and retail pharmacy services to help individuals and employers manage medical costs and access healthcare services.

It brought in $420.6B of sales in the 12 months to Sep 2026.

Led by David Joyner, President and Chief Executive Officer since 2024. CVS Health Corporation Form 10-K

Industry
Consumer staples
Based in
Woonsocket, Rhode Island
Trades on
NYSE as CVS

Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 3¢ was left as profit after every cost, interest and tax. The biggest cost is making what it sells, 56¢ of every dollar.

  • Making what it sells56¢
  • Everything else it takes to operate41¢
  • Interest and other costs1¢
  • Left as profit3¢
Totals of the four quarters to Sep 2026, from the company's own filings.

Who pays CVS Health, and for what?

CVS Health runs Aetna health insurance, the CVS Caremark pharmacy benefits business and about 9,000 CVS Pharmacy stores. It makes money from insurance premiums, from selling and managing prescription drugs for employers and health plans, and from store sales of medicines and everyday products. It also runs clinics and in-home health checks.

Employers, individuals, health plans and the US government pay it; federal government payments made up about 20% of total 2025 revenue, mostly through Medicare.

  • Health Services (CVS Caremark, clinics)

    Manages prescription drug benefits for about 87 million plan members and runs mail-order and specialty pharmacies, Oak Street Health primary care centers, MinuteClinic and Signify Health in-home checks. Segment figures include sales to other CVS units, so the three shares add up to more than 100%.

  • Health Care Benefits (Aetna)

    Health insurance for more than 37 million people through employers, Medicare Advantage, Medicare drug plans, Medicare Supplement and Medicaid. Most of this money comes from premiums. 2025 revenue was $143.4 billion.

  • Pharmacy & Consumer Wellness (CVS Pharmacy stores)

    About 9,000 stores that filled 1.8 billion prescriptions in 2025. Prescriptions made up 82.9% of this segment's sales, and front-store items like health, beauty and household goods made up 17.1%.

We don't have each line's share of sales for this company yet.

Where its work physically happens, beyond headquarters:

  • Health Care Benefits principal office — Hartford, United States. This 1.7 million-square-foot complex is the principal office of CVS Health's Health Care Benefits segment.
  • Hainesport distribution center — Hainesport, United States. Its automated systems replenish CVS Pharmacy stores across the Northeast and Mid-Atlantic with health, beauty and personal-care products.
  • Jersey City bulk distribution center — Jersey City, United States. The bulk distribution center expands supply capacity for CVS Pharmacy stores across the New York City region.
  • Chemung distribution center — Chemung, United States. CVS reported that this distribution center was built to support 350 pharmacy stores in the Northeast.
  • Flower Mound specialty mail pharmacy — Flower Mound, United States. This CVS Specialty mail-service pharmacy dispenses and delivers medications for patients with complex conditions.
See them on the globe

CVS Health 2025 Form 10-K

How is the business doing?

Sales grew from $268.7B in 2020 to $402.1B in 2025, about 8% a year.

Running the business leaves about 4¢ of each sales dollar as operating profit, about the same as 5¢ in 2020.

After paying for its upkeep and new investment, it had $15.6B of cash to spare in the 12 months to Sep 2026.

Sales$402.1B
20162025
Operating margin1%
20162025
Free cash flow$7.8B
20162025
Each bar is one fiscal year (2016–2025), summed from four published quarters; the latest is highlighted.

What does management say it's aiming for?

CVS Health says it exists to make health care simpler for people, and it wants to be America's most trusted health care company.

“Our purpose is to simplify health care one person, one family and one community at a time.”

CVS Health 2025 Form 10-K

Who is responsible for the plan?

  • David JoynerPresident and Chief Executive Officer

    Oversees enterprise strategy, operations, and governance across CVS Health's integrated healthcare, pharmacy services, and benefits businesses. Directs the connected healthcare enterprise combining health insurance, pharmacy benefit management, retail pharmacy dispensing, and care delivery clinics to generate diversified revenue.

  • Prem ShahExecutive Vice President and Group President

    Oversees operational performance and integrated execution across Pharmacy Services, Pharmacy & Consumer Wellness, and Health Care Delivery businesses. Drives core revenue generation across pharmacy benefit management, retail prescription fulfillment, consumer wellness products, and primary care clinic operations.

  • Tilak MandadiExecutive Vice President, Ventures and Chief Digital, Data, Analytics and Technology Officer

    Oversees enterprise data, artificial intelligence, digital architecture, consumer technology platforms, and corporate venture investments. Develops the digital and technology infrastructure that powers patient engagement, online pharmacy services, and omnichannel consumer care delivery.

Roles checked November 14, 2026.

What management says it is working on now:

  • Making Aetna profitable again

    Aetna's adjusted operating income fell from $5.6 billion in 2023 to $0.3 billion in 2024, then recovered to $2.9 billion in 2025. In mid-2026 the company credited its margin recovery plan for higher insurance profits and raised its 2026 outlook for the segment.

    CVS Health Q2 2026 results press release
  • Cutting back unprofitable lines

    Aetna left the individual public insurance exchanges in January 2026. The company also largely exited two Medicare cost-sharing programs for health systems in 2025, and it plans to close some Oak Street Health clinics in 2026.

    CVS Health 2025 Form 10-K
  • Connecting its businesses to lower costs

    Its strategy is to simplify care, keep people more engaged, lower costs and improve health results. It does this by linking its insurer, pharmacy benefits business, stores and clinics.

    CVS Health 2025 Form 10-K
  • Cheaper copies of costly drugs

    Through its Cordavis unit, CVS works with drugmakers to bring lower-cost copies of expensive biologic drugs to market. Its goal is more competition and lower drug costs for clients.

    CVS Health 2025 Form 10-K
  • Technology and AI

    The company is investing in data platforms, cloud systems, digital tools and artificial intelligence. It wants to automate work and make things easier for members, patients and doctors.

    CVS Health 2025 Form 10-K
Adjusted earnings per share (2026), full year 2026 (raised from $7.30 to $7.50)
$7.90 to $8.10
CVS Health Q2 2026 results press release
Earnings per share (2026, standard accounting), full year 2026
$6.84 to $7.04
CVS Health Q2 2026 results press release
Cash flow from operations, full year 2026
At least $11.5 billion
CVS Health Q2 2026 results press release
Health Care Benefits adjusted operating income, full year 2026
$5.03 billion to $5.37 billion
CVS Health Q2 2026 results press release
Adjusted earnings per share growth, three years starting from 2025 (through 2028)
Mid-teens average yearly growth
CVS Health Investor Day press release
Deployable cash, 2026 to 2028 combined
$55 billion to $60 billion
CVS Health Investor Day press release
Goals in management's own numbers. A target is a promise, not a result.

What's changing right now?

Growth is holding steady. In Q3 2026 it sold 5% more than a year earlier. The year before, quarters averaged 7%.

Its operating margin is wider than a year ago: 3¢ per sales dollar, against a loss of 3¢.

Since Oct 2026 the share price has fallen 5%, from $92.79 to $88.59.

Bull $366.46Base $232.05Bear $135.83Oct 22Nov 16 · $88.59
Daily closing prices we have recorded, set against our bear-to-bull range. Our price records start October 22, 2026.

Recently

Coming up

  • November 4, 2026

    Third-quarter 2026 results

    CVS will report third-quarter results and may update its 2026 outlook on a call at 8:00 a.m. Eastern time.

    CVS Health to hold third quarter 2026 earnings conference call
  • Payments affected in 2028

    Medicare bonus payments tied to 2027 star ratings

    More than 69% of Aetna's Medicare Advantage members are in plans rated 4 stars or higher for 2027, down from over 81% for 2026. These ratings decide which plans get bonus payments in 2028.

    Aetna 2027 Star ratings press release
  • During 2026

    Oak Street Health clinic closures

    The company plans to close some existing Oak Street Health primary care clinics during 2026 and has already recorded an $83 million charge for this.

    CVS Health 2025 Form 10-K

Our own estimate moved too: the base case went from $133.56 to $232.05 a share between our last two valuations. The biggest reason: Health Care Benefits Medical Benefit Ratio (Annual) moved from an unreported prior value to 94.2%, as reported in CVS Health Full Year 2025 Financial Results Release.

What could go wrong?

No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.

  1. Medical costs higher than planned

    Aetna sets most insurance prices months ahead and usually cannot raise them mid-year. If patients use more care than expected, profits drop quickly. The company expects use of care to stay high in 2026.

    From the company's own filingsWould hit how much of each sale it keepsCVS Health 2025 Form 10-K

  2. Dependence on government health programs

    About 20% of revenue comes from the federal government, mostly Medicare. Changes to Medicare or Medicaid payment rates, rules or funding could cut revenue and profit.

    From the company's own filingsWould hit how fast sales growCVS Health 2025 Form 10-K

  3. Falling Medicare quality ratings

    Medicare pays bonuses only to plans rated 4 stars or more. The share of Aetna members in such plans fell from 88% to over 81% in the 2026 ratings and to over 69% in the 2027 ratings, which could reduce bonus payments in 2028.

    From the company's own filingsWould hit how fast sales growAetna 2027 Star ratings press release

  4. Pressure on the pharmacy benefits business

    Clients are demanding lower prices and a bigger share of drugmaker rebates. Most states and the federal government have proposed or passed laws on pharmacy benefit managers, which could limit how this business operates and earns money.

    From the company's own filingsWould hit how much of each sale it keepsCVS Health 2025 Form 10-K

  5. Lawsuits and investigations

    In 2025 CVS recorded about $1.2 billion of charges from two court decisions over past practices, plus another $320 million for opioid lawsuits. More government audits or lawsuits could bring further fines or payouts.

    From the company's own filingsCVS Health 2025 Form 10-K

  6. Weak clinic results and store sales

    CVS took a $5.7 billion write-down in 2025 on its health care clinics business (mainly Oak Street Health and Signify Health) and plans to close some Oak Street clinics. Shoppers spending less, or switching to grocery, discount or online stores, could also reduce store sales.

    From the company's own filingsWould hit how fast sales growCVS Health 2025 Form 10-K

  7. Federal PBM transparent pricing reforms and state legislative mandates could reduce pass-through rebate volumes across CVS Caremark.

    From our researchWould hit how fast sales growFederal Trade Commission Interim Staff Report on PBMs

  8. Ongoing medical cost inflation in hospital contracts and specialty drug therapies may outpace premium rate indexation.

    From our researchWould hit how much of each sale it keepsAetna Health Care Benefits Underwriting Analysis

Is it a good business?

From 2016 to 2025 it earned between 2% and 13% on the capital invested in it, a median of 7%. Its cost of capital in the latest valuation is 6.8%; returns were above it in 6 of the 10 years.

From 2016 to 2025 it earned between -1% and 18% on its shareholders' equity, a median of 10%.

Over 10 years its operating margin ranged from 1¢ to 6¢ per sales dollar, a median of 4¢. Gross margin ran from 15¢ to 45¢.

derived computed from the filingsassumption cost of capital from the latest valuation
Return on invested capital3%
20162025

Cost of capital 6.8%

Return on equity2%
20162025
Return on invested capital is operating profit after tax (at the median effective rate, 25%) over debt plus equity less cash at each fiscal year end. Return on equity is net income over equity. Both are computed from published quarters.

The number of shares has held roughly steady over the past year.

It owes $48.9B more than it holds in cash, about 3.2 years of operating profit.

What might it be worth?

The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .

Today a share costs $88.59. Our put its value between $135.83 and $366.46, with $232.05 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .

Bear case, $135.83

This scenario assumes that high patient medical costs and lower prescription reimbursements keep profits subdued near recent low levels, slowing sales growth to a modest crawl.

Base case, $232.05

This scenario assumes that health insurance profit margins gradually recover from recent lows back toward historical norms, while pharmacy and clinic services deliver steady mid-single-digit sales gains.

Bull case, $366.46

This scenario assumes that healthcare insurance profits rebound strongly as medical claims normalize, while specialized pharmacy services and primary care clinics power sustained revenue expansion.

Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.

Why the gap?

The price expects less than we do.Margin of safety: 62%

At today's $88.59, the price makes sense if sales shrink about 11.5% a year. We assume they grow 4.5%. Over the last 5 years, sales grew 8.1% a year.

−15%−10%−5%0%+5%+10%+15%Price needs −11.5%We assume 4.5%Past 5 yrs 8.1%

Or, if sales grow 4.5% as we assume, the price works with a profit margin of 2.2% (we assume 4.8%).

Keep in mind: a low price can mean investors see a risk that isn't in the filings yet. Check the Full research tab for what could go wrong.

Do you think sales will shrink?

Try your own numbers

We're moderately sure of this range: it scores 66 out of 100 on our checks. The weakest point is terminal-value dependency.

Test the assumptions

Our base value of $232.05 rests on three assumptions. Change any of them to see how the value per share responds.

  • Revenue growth, 5-year average4.5%
  • Operating margin4.8%
  • Long-term growth rate2.5%

This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.

Base estimate

$232.05 161.9%

Build